Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06143696
Status:
RECRUITING
Last Update Posted:
2023-11-22
First Post:
2023-11-16
Brief Title:
QXZS in Menopausal Syndrome Based on 16S rRNA Sequencing Technology
Sponsor:
Yun Chen
Organization:
Jiangsu Province Hospital of Traditional Chinese Medicine
Study Overview
Official Title:
Study on the Heart Brain-gut Axis Mechanism of Qingxin Zishen Decoction in Treating Hot Flashes in Menopausal Syndrome Based on 16S rRNA Sequencing Technology
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to explore the differences of intestinal flora and saliva flora between menopausal women and the changes after medication to find the association between the two and menopausal syndrome The main questions it aims to answer are
What are the differences in intestinal flora and saliva flora in menopausal women with hot flashes and sweating
Whether these differences change after using traditional Chinese medicine and the association between intestinal salivary flora and menopausal syndrome
60 patients will be screened according to the clinical experimental criteria They will be randomly divided into trial group 30 cases and control group 30 cases The test group takes traditional Chinese medicine Qingxin Zishen decoction and the control group takes oral Femoston comparing the two groups with analysis of symptom improvement intestinal flora and salivary flora with 16S rRNA sequencing technology
What are the differences in intestinal flora and saliva flora in menopausal women with hot flashes and sweating
Whether these differences change after using traditional Chinese medicine and the association between intestinal salivary flora and menopausal syndrome
60 patients will be screened according to the clinical experimental criteria They will be randomly divided into trial group 30 cases and control group 30 cases The test group takes traditional Chinese medicine Qingxin Zishen decoction and the control group takes oral Femoston comparing the two groups with analysis of symptom improvement intestinal flora and salivary flora with 16S rRNA sequencing technology
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None